Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Cincinnati

Cincinnati, Ohio, United StatesNot linked to an institution yet

0running trials
5closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

No running trial is registered here.

Researchers

No researcher is linked here yet.

Closed trials

Terminated
A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.
NCT04840199· Phase 2· Source
Completed
B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B
NCT04193189· Phase 3· Source
Completed
Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1
NCT03739996· Phase 2· Source
Completed
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
NCT03635788· Phase 3· Source
Completed
Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men
NCT02720094· Phase 2/3· Source

Site data: ClinicalTrials.govUpdated 3 Nov 2026

Report an error